NL-OMON32777撤回不适用
Vaccination response in lymphoma patients treated with CHOP and rituximab - RIVAC
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Patients with non-Hodgkin's lymphoma, treated with rituximab (approximately 6-8 cycles) and who are in remission.
- •- Completion of rituximab therapy in the last twelve months before start of the study
- •- Age 18 years or older
- •- Signing of informed consent
排除标准
- •- Vaccination with Hib or pneumococcal vaccine in the last fifteen months before start of the study
- •- Fever at time of vaccination
- •- Previous/known allergic reaction to any of the components of the vaccines given
研究者
相似试验
尚未招募
不适用
Response to vaccination in lymphoma patients treated with CHOP and rituximab.cancer of the lymph nodes1004743810025320LymphomaNL-OMON38294Sint Antonius Ziekenhuis160
进行中（未招募）
不适用
Reponse to vaccination in patients with bonemarrowcancer who are treated with chemotherapy.multiple myelomaEUCTR2012-005713-39-NLSt. Antonius Hospital
已完成
2 期
Vaccination with recombinant lymphoma idiotype in indolent lymphoma in advanced stagesIndolent B cell lymphomaC82C83.0C83.1Small cell B-cell lymphomaFollicular lymphomaMantle cell lymphomaDRKS00000227Abteilung Innere Medizin IUniversitätsklinikum Freiburg42
已完成
1 期
Vaccination of cancer patients for preventing cancer developmentymphoma.B-cell lymphoma, unspecifiedIRCT138712071715N1Mazandaran University of Medical Sciences10
尚未招募
不适用
Efficienty of vaccination in patients with cancer who are treated with chemotherapy.lymphoma, non-hodgkins lymphoma, NHL, vaccination, influenza, humoral response, rituximab.lymfoom, non-hodgekin's lymfoma, NHL, vaccinatie, influenza, humorale respons, rituximab.NL-OMON23415St. Antonius Ziekenhuis Nieuwegein160